ABSTRACT: Reducing the burden of physical illness among people living with severe mental illnesses (SMI) is a key priority. Smoking is strongly associated with SMIs resulting in excessive smoking related morbidity and mortality in smokers with SMI. Smoking cessation advice and assistance from mental health practitioners would assist with reducing smoking and smoking-related harms in this group. This study examined the attitudes and practices of Australian mental health practitioners towards smoking cessation and tobacco harm reduction for smokers with SMI, including adherence to the 5As (ask, assess, advise, assist and arrange follow up) of smoking cessation. We surveyed 267 Australian mental health practitioners using a cross-sectional, online survey. Most practitioners (77.5%) asked their clients about smoking and provided health education (66.7%) but fewer provided direct assistance (31.1-39.7%). Most believed that tobacco harm reduction strategies are effective for reducing smoking related risks (88.4%) and that abstinence from all nicotine should not be the only goal discussed with smokers with SMI (77.9%). Many respondents were unsure about the safety (56.9%) and efficacy (39.3%) of e-cigarettes. Practitioners trained in smoking cessation were more likely (OR: 2.9, CI: 1.5-5.9) to help their clients to stop smoking. Community mental health practitioners (OR: 0.3, CI: 0.1-0.9) and practitioners who were current smokers (OR: 0.3, CI: 0.1-0.9) were less likely to adhere to the 5As of smoking cessation intervention. The results of this study emphasize the importance and need for providing smoking cessation training to mental health practitioners especially community mental health practitioners.
INTRODUCTION
Reducing the burden of physical illness among people with severe mental illnesses (SMI) has been identified as a key national priority (National Mental Health Commission, 2014) . Reducing smoking rates among this population is central to this aim. Research suggests that people with a SMI, such as schizophrenia, bipolar disorder and major depression are three to four times more likely to smoke compared to those without a SMI (Cooper et al. 2012; Lawrence et al. 2009 ). Smokers with SMI are heavier smokers, smoke more intensely and are more nicotine dependent compared to their counterparts in the general population (Lawrence et al. 2009) . Tobacco smoking, which is an established risk factor for heart disease, cancers and cerebrovascular diseases, contributes to the high morbidity and premature mortality among this population group, who experience a life expectancy 10-15 years lower than the general population (Lawrence et al. 2013) . The disproportionately high smoking rates among people with SMI have been attributed to neurobiological vulnerabilities to addiction, a tendency to use nicotine to alleviate the symptoms of mental illness and antipsychotic drugs, experiencing socio-economic disadvantage, low access to health services and pro-smoking attitudes of health practitioners (McNeill 2001) .
Smoking cessation and harm reduction in smokers with SMI
Research specific to smokers with SMI is limited. The available evidence suggests that many smokers with SMI want to quit smoking (Siru et al. 2010) . Interventions that are effective for increasing quit success among smokers without SMI are also effective for smokers with SMI (Banham & Gilbody 2010) . These include nicotine replacement therapy (NRT), prescription medications (e.g. varenicline and bupropion) and psycho-social interventions (Roberts et al. 2016) . Tobacco harm reduction (THR) options may also help to reduce smoking related harm for those individuals who are unable or unwilling to quit nicotine/tobacco . Potential THR strategies include switching partially or completely to clean nicotine products such as NRT (gum, patch, spray etc.), low nitrosamine smokeless tobacco (e.g. Swedish snus) and nicotine vaporisers like e-cigarettes (battery operated devices which produce an aerosol that is inhaled by the user) . There is some evidence that these options may help smokers with SMI to quit or reduce their smoking. For example, extended use (6 months) of NRT has been tested for maintaining smoking abstinence with some success in a small sample of smokers with schizophrenia (Dale Horst et al. 2005) . Two studies provide some preliminary evidence that nicotine vaporizers can help people with SMI to quit or reduce smoking (Caponnetto et al. 2013; O'Brien et al. 2015) . Further trials are underway (Sharma et al. 2016) .
Health practitioners' delivery of smoking cessation in SMI Health practitioner delivered smoking cessation advice has been shown to help general population smokers to quit smoking (Stead et al. 2008) . Smoking cessation guidelines, including the Royal Australian College of General Practitioner (RACGP) guidelines recommend intensive smoking cessation counselling, pharmacotherapy and close follow up for smoking cessation in people with SMI (RACGP 2011). These guidelines recommend the 5As approach ("Ask", "Assess", "Advise", "Assist" and "Arrange") to addressing smoking (RACGP 2011) . The 5As approach is designed to help practitioners remember the essential components of the smoking cessation counselling pathway (RACGP 2011). Due to their higher smoking prevalence and greater difficulty quitting, smokers with SMI should ideally receive more smoking cessation advice than general population smokers. However, research suggests they do not (Mitchell et al. 2015) . A US study found less than half (41%) of smokers with SMI received all the 5As of smoking cessation advice (Dixon et al. 2009) . A survey of American psychiatrists reported that they offered quit smoking advice to smokers at only 12.5% of patient visits (Himelhoch & Daumit 2003) .
Failure to provide adequate smoking cessation advice may be rooted in the beliefs that smokers with SMI do not want to quit smoking, that smoking is an important source of pleasure for this population, or that smoking is less harmful than other commonly cooccurring behaviours such as drug abuse and self-harm (Prochaska 2010) . Furthermore, mental health practitioners (practitioners who provide healthcare for people with SMI), may also lack training, sufficient time and confidence in their ability to deliver quit smoking interventions to smokers with SMI (Sheals et al. 2016) .
Health practitioners and THR
While there have been some studies on the practices and attitudes of mental health practitioners to providing smoking cessation advice (Sheals et al. 2016) , limited research has been carried out on practitioners' and mental health consumers' views on THR strategies (Harker & Cheeseman 2016; Moysidou et al. 2016; Pratt et al. 2016; Rooke et al. 2015) . Some previous studies have examined Australian mental health care providers' practices towards providing smoking cessation and reduction advice to people with SMI (Ashton et al. 2010; Dwyer et al. 2009; Lawn 2004; Wye et al. 2010 ) but none addressed views on THR options such as switching to ecigarettes and long term NRT. Studies from the US and Europe indicate that health professionals may hold negative attitudes towards THR practices (Beard et al. 2012; Kandra et al. 2014) . Despite the evidence that NRT does not increase psychiatric events nor is it associated with increased risk of myocardial infarction or death (Stead et al. 2012) , a study of English stop smoking practitioners and managers, found that 16% believed that the use of NRT for more than a year is harmful to health while 7.9% did not know (Beard et al. 2012) . On the other hand, there is a growing interest in e-cigarettes among the public as well as health professionals. About twothirds of physicians responding to a survey in the USA believed that e-cigarettes are helpful in smoking cessation and one-third reported recommending e-cigarettes to their patients (Kandra et al. 2014) . Similarly, despite having concerns about the safety and health effects of e-cigarettes, one-third of Greek health practitioners recommended e-cigarettes to their patients as a quit smoking aid (Moysidou et al. 2016) .
In light of the rapidly changing evidence and treatments for smoking cessation, prescription guidelines, and resources, it is important to understand the current behaviours and attitudes of front line staff who regularly interact with mental health consumers. The present study aimed to assess the practices and attitudes of Australian mental health practitioners towards assisting their clients to stop smoking and their beliefs about potential THR strategies for people with SMI.
METHODS

Participants
An online, cross-sectional, national survey collected data from a convenience sample of Australian health practitioners who have clients with SMI.
Questionnaire
The survey questionnaire (see online Table S1 ) was modelled on a similar survey undertaken amongst another health practitioners group (Ford et al. 2015) and incorporated inputs from researchers involved in smoking cessation research among people with co-morbidities and a clinician. It consisted of six parts:
Part 1: Demographic characteristics. Part 2 and 3: Practices related to smoking cessation covering activities from the 5As framework of smoking cessation (ask, assess, advise, assist and arrange follow up). The root question in these parts of the questionnaire asked the participants to "Please indicate how often you perform the following for mental health consumers with a SMI" followed by statements such as "Ask new adult mental health consumers about their smoking" and "Provide printed self-help materials on smoking cessation (e.g. brochure)". The response options were a five point Likert scale ranging from "always" to "never".
Part 4: Barriers faced by the participants in delivering smoking cessation interventions to their clients with SMI. The participants were asked to respond to 15 statements using a five-point Likert scales ranging from "strongly agree" to "strongly disagree".
Part 5: Practitioners' interest in smoking cessation resources. The root question was "Assuming each of the following resources and services were available, how likely would you be to use or recommend them to assist mental health consumers with SMI to quit smoking?" This was followed by statements such as "Refer mental health consumers to a quit smoking website for people with SMI". The response scale was a five point Likert scale ranging from "very likely" to "very unlikely", including an option of "don't know".
Part 6: Beliefs about THR. This consisted of seven statements about practitioners' beliefs about THR options such as smoking reduction, long term NRT use and use of e-cigarettes for smokers with SMI. The response scale was a six point Likert scale ranging from "very likely" to "very unlikely", including an option of "don't know". This paper reports findings from parts one, two, three and six. This paper reports findings from the first, second, third and sixth part of the questionnaire (See Table S1 ). Results from parts four and five will be reported elsewhere supported by additional qualitative inquiry.
Procedure
The survey was distributed via government and nongovernment organizations identified through Internet searches and authors' professional networks (see Table S2 ). This study was approved by the research ethics committee of the School of Public Health, The University of Queensland (RH04122015) and the Royal Brisbane and Women's Hospital Human Research Ethics Committee (HREC/15/QRBW/603).
The survey questionnaire was converted to an electronic format in the secure survey software Research Electronic Data Capture (REDCap). An email invitation which included the survey URL was sent to the identified organizations with a request to distribute the survey among their staff who work with people with SMI. Advertisements containing the URL were also placed in newsletters of professional bodies. Participants who clicked on the survey link were directed to the online participant information and consent form and were able to start the survey upon providing consent. At the end of the survey, participants were redirected to a web page that was not linked to the questionnaire, where they were offered a chance to win a travel gift voucher (AUD 2000) in a prize draw by submitting their contact details, in appreciation of their completing the survey.
Analysis
The data were analyzed in the statistical software SPSS (version 23, Chicago IL, USA). Descriptive statistics (e.g. percentages and means) were used to summarize participant responses. Binomial multivariable logistic regression models were used to examine predictors of adherence to the 5A framework of smoking cessation.
The dependent variables for analysis were constructed by transforming data from questions two and three of the questionnaire (see Tables S1, S5 and S6) . These statements were grouped to create a score for each of the five domains of the 5A framework as described in the RACGP guidelines (RACGP 2011). Points were awarded for each statement to which the participant answered "always" or "most of the time". A maximum of five points was available for each domain, such that a participant who answered 'always' or 'most of the time' to all statements would receive a total score of 25 (see Table S3 ). Dependent binomial variables were created for all 5A domains by dichotomizing the responses for each domain into 1 (those who answered 'always' or 'most of the time' for any of the statements within the domain) and 0 (for those who did not answer 'always' or 'most of the time' for any of the statements within that domain). A composite 5A variable was created where a value of 1 was given to participants who answered 'always' or 'most of the time' for at least one statement in all of the five domains, indicating participants who regularly practice the full 5As framework and 0 for those who did not.
Predictors used in the regression models were (See Table 1 ): (i) Type of health professional (ii) Location of practice (non-urban area compared to urban and metropolitan centres); (iii) Smoking status (current, daily and occasional smokers compared to non-smokers) (iv) Receipt of smoking cessation training.
RESULTS
Participant characteristics
Completed surveys were obtained from 267 out of 332 clicks on the survey link (80.4%). Participant characteristics are listed in Table 1 . The sample included allied health practitioners (24.7%), nurses (22.8%) community mental health practitioners (health practitioners with vocational training in mental health who provide services to people and family with SMI in their homes or community centres) (22.8%) and medical practitioners (13.9%). The majority of respondents worked in the public sector (69.7%) and practiced in an urban or metropolitan centre (61.8%). Fewer than half of the Adherence to the 5As Table 3 ) showed community mental health practitioners (OR: 0.3, CI: 0.1-0.9) were significantly less likely to regularly practice the 5As compared to medical practitioners. Compared to medical practitioners, all other health practitioners were less likely (ORs ranged from 0.2 to 0.3) to follow up a client's quit attempt or provide relapse prevention advice to their clients. Practitioners from non-urban areas were twice as likely (OR: 1.9, CI: 1.1-3.2) to assess smoking status of their clients. Practitioners who were current smokers were less likely to advise their clients to quit smoking (OR: 0.3, CI: 0.1-0.8) or deliver all of the 5As regularly (OR: 0.3, CI: 0.1-0.9). Training was a significant predictor for practicing the four out of 5As. Practitioners trained for smoking cessation were two to three times more likely to ask, assess, assist and arrange follow-up for their clients who smoked. Training did not significantly predict advising a client to stop smoking (OR: 1.6, CI: 0.9-2.7) or regularly performing all the 5As (OR: 1.7, CI: 0.9-2.9) for clients who smoke.
Attitudes towards THR in consumers with SMI
There was a high level of support for THR options for smokers with SMI (Fig. 1) . The majority of Table S4 shows that nurses were more likely to agree that cutting down smoking reduces smoking related risk (OR: 2.8, CI: 1.0-7.3) and advise their clients to reduce their smoking (OR: 2.7, CI: 1.1-6.6). Practitioners who were current smokers were more likely agree that switching completely to NRT (OR: 2.5, CI: 1.1-5.9) or vaping (OR: 2.1, CI: 1.0-4.5) as a long term substitute for cigarettes may reduce smoking-related risk.
Health practitioners who had received smoking cessation training had higher odds of giving smoking reduction advice (OR: 2.0, CI: 1.2-3.4) and disagreeing with the statement that vaping is too harmful to recommend to smokers who can't quit or aren't able to quit (OR: 2.0, CI: 1.1-3.6) ( Table 4) .
DISCUSSION
This study examined the current smoking cessation practices and attitudes of Australian health practitioners towards THR strategies for smokers with SMI. We used the 5As framework to determine the adequacy of smoking cessation practices by participants (RACGP 2011) . Studies have shown that providing assistance with advice to stop smoking, increases quit rates among general population smokers (Aveyard et al. 2012) . Participants in our survey reported asking (77.5%) and assessing (59.6%) their clients for smoking more often than participants of a previous Australian study (26.1%), which surveyed a similar sample to ours, but in one state (South Australia) only (Ashton et al. 2010) .
Our survey was open to mental health practitioners in all Australian states and territories. We found that while most practitioners regularly ask about smoking status, few provide comprehensive smoking cessation assistance to their clients. This is consistent with similar studies undertaken with general and mental health practitioners, which report that a large percentage of practitioners ask their clients about smoking status but fewer provide assistance to quit (Ferketich et al. 2006; Johnson et al. 2009 ).
Most practitioners regularly performed at least one activity from the 5As framework, but less than a third performed all of them 'always' or 'most of the time'. Training in smoking cessation was an important predictor of regularly practicing the 5As, however fewer than 50% of respondents had been trained in providing 2)* 1.6 (0.9-2.7) 2.9 (1.5-5.9)* 2.2 (1.2-3.8)* 1.7 (0.9-2.9) *Statistically significant (P ≤ 0.05).
smoking cessation assistance. These results are similar to those reported by a metanalysis of eight studies, which assessed the effectiveness of providing smoking cessation training to health care professionals on provision of quit smoking advice (Carson et al. 2012) . Further, quit smoking advice delivered by trained professionals is associated with better abstinence rates than when delivered by untrained individuals (Carson et al. 2012) . Trained practitioners in our sample were also more supportive of harm reduction strategies including switching to vaping and cutting down (Table 4) . Increased knowledge about the effectiveness and safety of NRT gained during smoking cessation training may result in increased acceptance of approaches such as these, even if not actively addressed in the training. Disappointingly, fewer than half of the practitioners in our survey had received smoking cessation training. Many cessation resources are available which could increase the success rate of quit attempts by smokers with SMI, such as self-help materials, quit line referrals and cessation pharmacotherapy, however these appeared to be underutilized in our sample. Three types of cessation pharmacotherapy (nicotine patches, bupropion and varenicline) are publicly subsidized in Australia under the Pharmaceutical Benefits Scheme (PBS). Two recent systematic reviews and meta-analyses of clinical trials reported that bupropion and varenicline increase the odds of successfully quitting by four to five times compared to a placebo among smokers with SMI (Roberts et al. 2016; Wu et al. 2016) . The reasons for low rates of assistance with pharmacotherapy could be lack of training and knowledge or authority to prescribe some smoking cessation medications (varenicline and bupropion). Provision of subsidized NRT for disadvantaged smokers is considered beneficial by staff of consumer service organisations (Bryant et al. 2010) . Absence of such subsidies for most NRTs (except for the patch which is subsidized via PBS) may deter mental health practitioners from recommending them to their clients. Despite the superior smoking cessation efficacy of varenicline, some practitioners may be hesitant to prescribe it for smokers with SMI, due to concerns about neuropsychiatric adverse events. There is evidence that smokers with SMI are not more likely to experience adverse events with varenicline compared to other stop smoking medications and general population smokers (Anthenelli et al. 2016; Roberts et al. 2016; Wu et al. 2016) . However, as recommended by smoking cessation guidelines, some effects may warrant caution and close patient monitoring when prescribing these medications for people with SMI (RACGP 2011).
The prevalence of smoking among our respondents was similar to that of the general Australian population (Australian Government: The Department of Health 2016). Practitioners who smoke were less likely to practice the 5As compared to non-smokers. This finding is similar to the results from a meta-analysis of 20 studies which found that smokers are less likely to give quit smoking advice to their patients compared to non-smokers (Duaso et al. 2014) . Belief in the "right to smoke", feeling like a hypocrite and fear of offending the client and affecting the therapeutic relationship may be barriers that decrease health practitioners' willingness to deliver smoking cessation assistance if they smoke (Cancer Council NSW 2008) . For example, one Australian study found that the majority of Australian mental health nurses who smoked believed in "smoking rights" of mental health consumers (Dwyer et al. 2009 ). Compared to non-smokers, more mental health practitioners in the UK who smoked believed that addressing smoking in their clients would adversely affect their therapeutic relationship (Harker & Cheeseman 2016) .
Smokers with SMI often have greater nicotine dependence and experience substantial difficulty in quitting (McNeill 2001; Sharma et al. 2016) . Hence, harm reduction strategies which don't require complete abstinence from nicotine may be particularly useful for smokers with SMI who are unable or unwilling to quit smoking using traditional abstinence-focussed methods (Sharma et al. 2016) . The majority of our respondents agreed that non-abstinence based approaches were appropriate for reducing the harms caused by smoking among people with SMI. However, the majority (especially nurses) erroneously believed that cutting down the number of cigarettes smoked per day substantially reduced the risk of smoking related harms. Cutting down may be a useful first step toward quitting; however, reducing the number of cigarettes smoked per day has not been found to reduce long term mortality in population based studies (Godtfredsen et al. 2002) .
Whether smokers with SMI should be encouraged to switch to vaping to reduce their health risks is controversial (Sharma et al. 2016) . Our questions about views on switching to vaping as a THR strategy elicited a high proportion of neutral or 'don't know' responses, indicating a high degree of uncertainty about this strategy among our respondents. However, of those who had an opinion, more agreed than disagreed that switching to vaping could assist smokers with SMI to reduce their health risk. The uncertainty about vaping may reflect the emergent and contested evidence-base regarding the safety and efficacy of e-cigarettes which has led to debates about whether health practitioners should recommend smokers switching to vaping (McNeill 2016) . Current Australian policies ban the sale of non-therapeutic nicotine products, such as e-cigarettes and nicotine containing e-liquids, with the exception of tobacco intended for smoking (Douglas et al. 2015) . Some professional organizations, such as the Australian Medical Association, have issued position statements which do not recognize e-cigarettes as cessation aids (AMA 2015) . By contrast, public and mental health organisations in the UK such as Royal College of Psychiatrists and Public Health England recommend switching to vaping nicotine for smokers who cannot or will not quit smoking (Public Health England 2015; RCPSYCH, 2015) . Developing the evidence base concerning vaporised nicotine as a THR strategy, particularly for high priority groups, such as smokers with SMI is urgently needed.
Practitioners who smoked were more likely to be supportive of THR strategies such as use of NRT or ecigarettes as long-term substitutes for cigarettes. One possible reason for our finding could be that practitioners' lived experience of nicotine addiction might increase knowledge about and receptiveness to a wide range of smoking cessation interventions, including non-abstinence strategies (Pelkonen & Kankkunen 2001) .
Strengths and Limitations
The respondents in this survey represented a wide range of mental health professionals, including nurses, social workers and community mental health practitioners. These health practitioners are closely involved in the routine health care of people with SMI which provides opportunities to deliver brief interventions. As our sample was a convenience sample obtained by widespread distribution of a survey invitation through relevant organisations and professional bodies (see Table S2 ), we are unable to determine a response rate or the representativeness of the sample. Our sample size of 267 is comparable to other similar surveys among mental health practitioners (Connolly et al. 2013; Dwyer et al. 2009 ). Our respondents may also represent those most interested in the topic of smoking cessation and might be more motivated to engage in smoking cessation activities; hence our results are likely to be conservative and over-rather than under-estimate the engagement of mental health practitioners in smoking cessation activities.
CONCLUSION
This study reports the findings of a national survey which assessed Australian mental health practitioners' practices and attitudes towards smoking cessation and THR options such as e-cigarettes. We found that smoking cessation training and being a non-smoker are important predictors of delivery of smoking cessation assistance. Nurses were more likely to endorse cutting down the number of cigarettes smoked as a THR strategy, despite little evidence that this substantially reduces smoking related harms. The majority of respondents supported THR rather than only nicotine abstinence for smokers with SMI.
RELEVANCE FOR CLINICAL PRACTICE
Firstly, this study highlighted the ongoing challenge of mobilising mental health practitioners to transition from just asking/assessing smoking status to providing smoking cessation interventions during clinical consultations. Training mental health practitioners in smoking cessation may increase the delivery of comprehensive smoking cessation assistance to smokers with SMI and also improve the efficacy of this assistance. Secondly, responsibility for delivering smoking cessation assistance should be shared across all health workers who work with people with SMI. All practitioners including nursing and medical practitioners, community mental health workers as well as allied health practitioners should be given smoking cessation training. Government and non-government organizations may like to consider how they can provide and incentivize training of mental health professionals, to deliver evidence-based smoking cessation assistance to people with SMI (Cancer Council NSW 2008) . Thirdly, considering the high level of support for THR, it would be useful for these training programs to incorporate harm reduction options, such as long term use of NRT and accurate information on the current evidence on e-cigarettes. This would help them address the increasing inquiries about these products from consumers with SMI. Lastly, mental health practitioners who smoke should be encouraged and assisted to stop smoking.
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